Multimarker approach for diagnosis of acute myocardial infarction: Better answers need better questions

Clinical Chemistry

Volumn 55, Issue 1, 2009, Pages 9-11

  Lindahl, Bertil ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; TROPONIN I;

ACUTE HEART INFARCTION; ATHEROSCLEROTIC PLAQUE; BLOOD LEVEL; CLINICAL CHEMISTRY; DIAGNOSTIC ACCURACY; EDITORIAL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; PREVALENCE; THORAX PAIN;

BIOLOGICAL MARKERS; HUMANS; IMMUNOASSAY; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; SENSITIVITY AND SPECIFICITY; TROPONIN I;

EID: 58149234834     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2008.117572     Document Type: Editorial

References (19)

1. McCaig L, Ly N. National Hospital Ambulatory Medical Care Survey, 2000: emergency department summary. Hyattsville (MD): Department of Health and Human Services, CDC, National Center for Health Statistics; 2002. 31 p. (Advance Data no. 326).
2. Thygesen K, Alpert JS, White HD. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Circulation 2007;116:2634-53.
3. Labugger R, Organ L, Collier C, Atar D, Van Eyk JE. Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation 2000;102:1221-6.
4. Apple FS. Increased concentrations of cardiac troponin I are equivalent to increased cardiac troponin T in identifying chest pain patients at short-term risk of myocardial infarction. Clin Chem 1998;44:1786-9.
5. Mitchell, AM, Garvey JL, and JA Kline. Multimarker panel to rule out acute coronary syndromes in low-risk patients. Acad Emerg Med 2006;13:803-6.
6. McCann CJ, Glover BM, Menown IB, Moore MJ, McEneny J, Owens CG, Smith B. Novel biomarkers in early diagnosis of acute myocardial infarction compared with cardiac troponin T. Eur Heart J [Epub ahead of print 2008 Aug 5].
7. Apple FS, Smith SW, Pearce LA, Murakami MM. Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome. Clin Chem 2008;55:93-100.
8. James SK, Lindahl B, Siegbahn A, Stridsberg M, Venge P, Armstrong P, et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies to Open Occluded Arteries (GUSTO)-IV substudy. Circulation 2003;108:275-81.
9. Kelly D, Khan SQ, Thompson M, Cockerill G, Ng LL, Samani N, Squire IB. Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction. Eur Heart J 2008;29:2116-24.
10. Brennan ML, Penn MS, Van Lente F, Nambi V, Shishehbor MH, Aviles RJ, Goormastic M. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 2003;349:1595-604.
11. Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104-11.
12. Esporcatte R, Rey HC, Rangel FO, Rocha RM, Mendonça Filho HT, Dohmann HF, Albanesi Filho FM. Predictive value of myeloperoxidase to identify high risk patients admitted to the hospital with acute chest pain. Arq Braa Cardiol 2007;89:341-7.
13. Collinson PO, Gaze DC. Biomarkers of cardiovascular damage and dysfunction - an overview. Heart Lung Circ 2007;16 Suppl 3:S71- 82.
14. Gunduz A, Mentese A, Turedi S, Karahan SC, Mentese U, Eroglu O, et al. Serum ischaemia-modified albumin increases in critical lower limb ischaemia. Emerg Med J 2008;25:351-3.
15. Lindahl B, Venge P, Wallentin L, BIOMACS Study Group. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. Coron Artery Dis 1995;6:321-8.
16. Eggers KM, Oldgren J, Nordenskjöld A, Lindahl B. Diagnostic value of serial measurement of cardiac markers in patients with chest pain: Limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. Am Heart J 2004;148:574-81.
17. Lewis GD, Wei R, Liu E, Yang E, Shi X, Martinovic M, et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 2008;118:3503-12.
18. Gustafsson G, Dellborga M, Lindahl B, Wallentin L. Early diagnosis and exclusion of acute myocardial infarction by two hours' vector-ECG and determination of either myoglobin or CK-mb. BIOMACS study. Biochemical Markers in Acute Coronary Syndromes. Scand Cardiovasc J 2000;34:172-7.
19. Kontos MC, Jesse RL, Anderson FP, Schmidt KL, Ornato JP, Tatum JL. Comparison of myocardial perfusion imaging and cardiac troponin I in patients admitted to the emergency department with chest pain. Circulation 1999;99:2073-8.